End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).

被引:0
作者
Shah, Bijal D.
Bishop, Michael Russell
Oluwole, Olalekan O.
Logan, Aaron
Baer, Maria R.
Donnellan, William Bruce
Carr-O'Dwyer, Kristen Marie
Holmes, Houston
Arellano, Martha Lucia
Ghobadi, Armin
Pagel, John M.
Lin, Yi
Cassaday, Ryan Daniel
Park, Jae Hong
Mardiros, Armen
Shen, Tong
Goyal, Lovely
Vezan, Remus
Jain, Rajul K.
Wierda, William G.
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[6] Sarah Cannon Res Inst, Nashville, TN USA
[7] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[8] Texas Oncol, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[9] Winship Canc Inst, Atlanta, GA USA
[10] Washington Univ, Sch Med, St Louis, MO USA
[11] Siteman Canc Ctr, St Louis, MO USA
[12] Swedish Canc Inst, Seattle, WA USA
[13] Mayo Clin, Rochester, MN USA
[14] Univ Washington, Sch Med, Seattle, WA USA
[15] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[17] Kite, Santa Monica, CA USA
[18] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7006
引用
收藏
页数:2
相关论文
共 50 条
[21]   KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy, in patients with relapsed/refractory mantle cell lymphoma: results from phase 2 of ZUMA-2 [J].
Wang, M. ;
Munoz, J. ;
Goy, A. ;
Locke, F. ;
Jacobson, C. ;
Hill, B. ;
Timmerman, J. ;
Holmes, H. ;
Jaglowski, S. ;
Flinn, I. ;
McSweeney, P. ;
Miklos, D. ;
Pagel, J. ;
Kersten, M. J. .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 :28-29
[22]   ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL) [J].
Shah, B. ;
Castro, J. ;
Goekbuget, N. ;
Kersten, M. Jose ;
Hagenbeek, T. ;
Wierda, W. ;
Schiller, G. ;
Bot, A. ;
Rossi, J. M. ;
Jiang, Y. ;
Navale, L. ;
Stout, S. ;
Aycock, J. ;
Wiezorek, J. ;
Jain, R. .
ANNALS OF ONCOLOGY, 2016, 27
[23]   ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) [J].
Lee, D. W. ;
Wayne, A. S. ;
Huynh, V. ;
Handgretinger, R. ;
Pieters, R. ;
Michele, G. ;
Baruchel, A. ;
Feuchtinger, T. ;
Bertrand, Y. ;
Hemiston, M. ;
Brown, P. A. ;
Rossi, J. ;
Jiang, Y. ;
Navale, L. ;
Stout, S. ;
Aycock, J. ;
Mardiros, A. ;
Wiezorek, J. ;
Jain, R. .
ANNALS OF ONCOLOGY, 2017, 28
[24]   ZUMA-4 PHASE 1: KTE-X19, AN ANTI-CD19 CAR T CELL THERAPY, IN CHILDREN AND ADOLESCENTS WITH R/R B-ALL [J].
Wayne, Alan ;
Van Huynh ;
Hijiya, Nobuko ;
Rouce, Rayne ;
Brown, Patrick ;
Krueger, Joerg ;
Rytting, Michael ;
Kitko, Carrie ;
Dela Ziga, Edward ;
Hermiston, Michelle ;
Richards, Michael ;
Baruchel, Andre ;
Mardiros, Armen ;
Shen, Tong ;
Goyal, Lovely ;
Vezan, Remuz ;
Jain, Rajul ;
Lee, Daniel .
PEDIATRIC BLOOD & CANCER, 2019, 66
[25]   Production of Anti-CD19 CAR T Cells for ZUMA-3 and-4: Phase 1/2 Multicenter Studies Evaluating KTE-C19 in Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) [J].
Sabatino, Marianna ;
Choi, Kenny ;
Chiruvolu, Vijay ;
Better, Marc .
BLOOD, 2016, 128 (22)
[26]   2-year update of KTE-X19 in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3 [J].
Shah, Bijal D. ;
Ghobadi, Armin ;
Oluwole, Olalekan O. ;
Logan, Aaron C. ;
Boissel, Nicolas ;
Cassaday, Ryan D. ;
Forcade, Edouard ;
Bishop, Michael R. ;
Topp, Max S. ;
Tzachanis, Dimitrios ;
O'Dwyer, Kristen M. ;
Arellano, Martha L. ;
Lin, Yi ;
Baer, Maria R. ;
Schiller, Gary J. ;
Zhou, Lang ;
Schuberth, Petra C. ;
Masouleh, Behzad Kharabi ;
Houot, Roch .
ANNALS OF ONCOLOGY, 2023, 34 :S1389-S1389
[27]   High Rates of Minimal Residual Disease-Negative (MRD-) Complete Responses (CR) in Adult and Pediatric and Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) Treated With KTE-C19 (Anti-CD19 Chimeric Antigen Receptor [CAR] T Cells): Preliminary Results of the ZUMA-3 and ZUMA-4 Trials [J].
Shah, Bijal ;
Van Huynh ;
Sender, Leonard S. ;
Lee, Daniel W., III ;
Castro, Januario E. ;
Wierda, William G. ;
Dietz, Andrew C. ;
Schiller, Gary J. ;
Kersten, Marie Jose ;
Handgretinger, Rupert ;
Brown, Patrick ;
Gore, Lia ;
Goekbuget, Nicola ;
Rosenthal, Joseph ;
Sabatino, Marianna ;
Bot, Adrian ;
Rossi, John M. ;
Jiang, Yizhou ;
Navale, Lynn ;
Stout, Shanna ;
Aycock, Jeff S. ;
Wiezorek, Jeff ;
Jain, Rajul ;
Wayne, Alan S. .
BLOOD, 2016, 128 (22)
[28]   Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL). [J].
Frey, Noelle V. ;
Shaw, Pamela A. ;
Hexner, Elizabeth O. ;
Gill, Saar ;
Marcucci, Katherine ;
Luger, Selina M. ;
Mangan, James K. ;
Grupp, Stephan A. ;
Maude, Shannon L. ;
Ericson, Solveig ;
Levine, Bruce ;
Lacey, Simon F. ;
Melenhorst, Jan J. ;
June, Carl H. ;
Porter, David L. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[29]   Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia [J].
Gu, Runxia ;
Liu, Fang ;
Zou, Dehui ;
Liu, Bingcheng ;
Liu, Wei ;
Chen, Xiaojuan ;
Liu, Kaiqi ;
Guo, Ye ;
Gong, Xiaoyuan ;
Lv, Rui ;
Chen, Xia ;
Zhou, Chunlin ;
Zhong, Mengjun ;
Xu, Yingxi ;
Wang, Huijun ;
Wei, Hui ;
Mi, Yingchang ;
Qiu, Lugui ;
Lv, Lulu ;
Wang, Min ;
Wang, Ying ;
Zhu, Xiaofan ;
Wang, Jianxiang .
BLOOD, 2019, 134
[30]   UPDATED RESULTS FROM ZUMA-4: A PHASE 1/2 STUDY OF KTE-C19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA [J].
Lee, D. W. ;
Wayne, A. S. ;
Huynh, V. ;
Handgretinger, R. ;
Brown, P. A. ;
Pieters, R. ;
Dietz, A. C. ;
Pulsipher, M. A. ;
Rossi, J. ;
Mardiros, A. ;
Jiang, Y. ;
Navale, L. ;
Aycock, J. ;
Stout, S. ;
Wiezorek, J. ;
Jain, R. .
HAEMATOLOGICA, 2017, 102 :346-347